Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 1088  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others

IJD SYMPOSIUM

Nephrogenic systemic fibrosis: Review of 408 biopsy-confirmed cases

Zou Zhitong, Ma Lin

Year : 2011| Volume: 56| Issue : 1 | Page no: 65-73

   This article has been cited by
 
1 Enhancing the Imaging and Biosafety of Upconversion Nanoparticles through Phosphonate Coating
Ruibin Li,Zhaoxia Ji,Juyao Dong,Chong Hyun Chang,Xiang Wang,Bingbing Sun,Meiying Wang,Yu-Pei Liao,Jeffrey I. Zink,Andre E. Nel,Tian Xia
ACS Nano. 2015; 9(3): 3293
[Pubmed]  [Google Scholar] [DOI]
2 Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents
Emmanuil Smorodinsky,David S. Ansdell,Zeke W. Foster,Sameer M. Mazhar,Irene Cruite,Tanya Wolfson,Sebastian B. Sugay,Gabriella Iussich,Masoud Shiehmorteza,Yuko Kono,Alexander Kuo,Claude B. Sirlin
Journal of Magnetic Resonance Imaging. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
3 Nephrogenic Systemic Fibrosis Risk and Liver Disease
Robert F. Hanna,Lee A. Finkelstone,Daniel S. Chow,Vesselin Z. Miloushev,Mark R. Escudero,Stephen M. Lagana,Martin R. Prince
International Journal of Nephrology. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
4 Half-dose gadoxetic acid-enhanced liver magnetic resonance imaging in patients at risk for nephrogenic systemic fibrosis
Kyoung Doo Song,Seong Hyun Kim,Jisun Lee,Kyung A. Kang,Joungyoun Kim,Heejin Yoo
European Journal of Radiology. 2014;
[Pubmed]  [Google Scholar] [DOI]
5 Gadolinium and nephrogenic systemic fibrosis: an update
Alex Weller,Joy L Barber,Øystein E Olsen
Pediatric Nephrology. 2013;
[Pubmed]  [Google Scholar] [DOI]
6 Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
Gilbert Deray,Olivier Rouviere,Lorenzo Bacigalupo,Bart Maes,Thierry Hannedouche,François Vrtovsnik,Claire Rigothier,Jean-Marie Billiouw,Paolo Campioni,Joaquin Ferreiros,Daniel Devos,Daniel Alison,François Glowacki,Jean-Jacques Boffa,Luis Marti-Bonmati
European Radiology. 2013; 23(5): 1250
[Pubmed]  [Google Scholar] [DOI]
7 Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
Theresa Reiter,Oliver Ritter,Martin R Prince,Peter Nordbeck,Christoph Wanner,Eike Nagel,Wolfgang Bauer
Journal of Cardiovascular Magnetic Resonance. 2012; 14(1): 31
[Pubmed]  [Google Scholar] [DOI]
8 Stealth Rare Earth Oxide Nanodiscs for Magnetic Resonance Imaging
Mark J. Bailey,Rob van der Weegen,Piper J. Klemm,Suzanne L. Baker,Brett A. Helms
Advanced Healthcare Materials. 2012; 1(4): 437
[Pubmed]  [Google Scholar] [DOI]
9 Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging
Christopher M. Andolina,Piper J. Klemm,William C. Floyd,Jean M. J. Fréchet,Kenneth N. Raymond
Macromolecules. 2012; 45(22): 8982
[Pubmed]  [Google Scholar] [DOI]

 

Read this article